Tysabri Now Linked to Severe Liver Damage
Tysabri Linked to Severe Liver Damage. Tysabri, a controversial drug used to treat Multiple Sclerosis (MS) manufactured by Biogen Idec Inc. and Elan Corp. has been linked to serious liver damage. This liver failure can occur within six days of the first dose of Tysabri. Tysabri, which was removed from the market in 2005 … [Read more...]
MS DRUG (TYSABRI) RESPONSIBLE FOR RARE BRAIN DISEASE
MS Drug Tysabri May Cause Rare Brain Disease. The FDA has been informed by Biogen Idec Inc. That a fourth person may now have died from a rare brain disease known as progressive multifocal leukoencephalopathy (PML). deaths from PML which had led to the suspension of the drug After being treated with its multiple … [Read more...]
